Heron Therapeutics, Inc.

NASDAQ:HRTX

Biotechnology

Healthcare
$0.26 +3.74%

+$0.01 today

Market cap
$50.25M
Beta
1.57
P/E (TTM)
-2.5
EPS (TTM)
-$0.16
52W Low $0.38High $2.30

Volume 3.60M

Average 2.90M

Balance Sheet

Inspect the capital base behind the business.

Assets

$255.88M

FY 2025 · Annual

+9.7% YoY

Liabilities

$241.54M

FY 2025 · Annual

-9.5% YoY

Equity

$14.33M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents90.54M15.36M28.68M25.8M28.65M
Short-term Investments67.04M69.49M51.73M33.48M17.98M
Net Receivables35.5M52.05M60.14M78.88M89.59M
Inventory48.38M54.57M42.11M53.16M92.75M
Other Current Assets013.96M6.12M17.69M9.1M
Total Current Assets254.42M205.44M188.77M209.01M238.07M
Property, Plant & Equipment (Net)33.56M29.81M25.6M17.65M12.4M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets17.72M15.71M8.13M6.48M5.41M
Total Non-current Assets51.28M45.52M33.73M24.13M17.81M
Total Assets305.71M250.95M222.51M233.15M255.88M
Account Payables3.87M3.59M3.8M11.71M8.99M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities13.48M11.28M7.85M7.96M8.61M
Total Current Liabilities71.06M82.36M79.69M91.46M96.1M
Long-term Debt149.08M149.28M173.75M174.73M140.64M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities0241K241K615K4.81M
Total Non-current Liabilities157.08M155.02M176.79M175.34M145.45M
Total Liabilities228.14M237.38M256.48M266.8M241.54M
Common Stock1.02M1.19M1.5M1.52M1.88M
Retained Earnings(1.61B)(1.8B)(1.91B)(1.92B)(1.94B)
Accumulated OCI(6K)(19K)13K13K4K
Other Stockholders Equity00000
Minority Interest00000
Total Equity77.57M13.57M(33.97M)(33.65M)14.33M
Total Debt159.5M157.48M179.63M177.76M140.64M
Net Debt68.95M142.11M150.95M151.96M111.99M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$26.1M
Short-term Investments$18.7M
Receivables$83.7M
Inventory$92.5M
Other Current$8.0M
Total Current Assets$229.0M
PP&E (Net)$12.0M
Other Non-current$5.2M
Total Non-current Assets$17.2M
Total Assets$246.2M

Analysis

Selected assets total $246.2M for Latest. The largest visible component is Inventory at $92.5M, about 37.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 10, 2026
8-KCurrent reportNov 9, 2026
8-KCurrent reportNov 9, 2026
DEFA14ADEFA14A filingNov 9, 2026
DEFA14ADEFA14A filingNov 9, 2026

How much cash does HRTX have?

Heron Therapeutics, Inc. (HRTX) reported $28.65M in cash and equivalents in fiscal 2025.

How much debt does HRTX carry?

Heron Therapeutics, Inc. (HRTX) reported $140.64M of total debt, with net debt of $111.99M.